JD vs KURA · P/E 7.6, rev $187.20B vs rev $20.9M
JD.com Inc Adr (JD) versus Kura Oncology Inc (KURA) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
JD currently screens at market cap $45.56B and trailing P/E 7.6. KURA currently screens at market cap $861.1M.
Not investment advice. Open the JD and KURA stock pages for the full models.
Not investment advice.